AstraZeneca Receives EU Approval for Klygefa in Adults With Myasthenia Gravis
AstraZeneca says the European Commission approved Klygefa for adults with generalized myasthenia gravis.
AstraZeneca says the European Commission approved Klygefa for adults with generalized myasthenia gravis.